Recalls / Active ingredient / Tiotropium Bromide Monohydrate
Tiotropium Bromide Monohydrate
5 FDA drug recalls involving the active ingredient “Tiotropium Bromide Monohydrate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-01-26 | Class II | SPIRIVA HANDIHALER (tiotropium bromide inhalation powder) 18 mcg/Capsule, 30 capsules, 3 blister cards, each c | CARDINAL HEALTHCARE |
| 2021-03-15 | Class II | Spiriva HandiHaler (tiotropium bromide inhalation powder) For Oral Inhalation Only 18 mcg (as tiotropium) per | Cardinal Health Inc. |
| 2017-12-14 | Class II | SPIRIVA HandiHaler (tiotropium bromide inhalation powder) 18 mcg/capsule (90 capsules (unit dose blisters) pe | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 2014-03-27 | Class III | Spiriva HandiHaler (tiotropium bromide inhalation powder), Do Not Swallow Spiriva Capsules, For Use With Handi | Boehringer Ingelheim Roxane Inc |
| 2013-08-30 | Class III | SPIRIVA HandiHaler (Tiotropium Bromide Inhalation Powder) Capsules 18 mcg per dose, Rx only, a) 10 count blist | Boehringer Ingelheim Roxane Inc |